Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease
RecruitingNCT04673643Phase: PHASE2Started 2021-07-01
Summary
Objective: To evaluate the effect of transcutaneous auricular vagus nerve stimulation (taVNS) for the patients with dry eye disease with meibomian gland dysfunction. Methods: We enrolled 256 patients
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Beijing Tongren HospitalBeijing, China
Wu DongBeijing, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT04673643